Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity

L.A. McKeown

December 23, 2024

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Daily News

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Michael O'Riordan

October 03, 2024

News Daily News

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

Todd Neale

August 12, 2024

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

News Daily News

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Yael L. Maxwell

July 29, 2024

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

News Daily News

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

Michael O'Riordan

June 21, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

News Daily News

Injectable Semaglutide Shortage Forces Physicians to Pivot

Todd Neale

February 05, 2024

News Daily News

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

Todd Neale

February 02, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

Advertisement

Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity

December 2024 Dispatch for the CV Team

November 2024 Dispatch for the CV Team

Cramming Weekly Physical Activity Into 1 or 2 Days Still Yields Benefits

Studies Highlight Rapid Growth of Semaglutide Use, Risks of Some Online Sources

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Schoolwide Intervention May Improve Obesity Outcomes Over Time

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Bariatric Surgery Reduces Hard Events in Obese Patients With Sleep Apnea

TCTMD’s Top 10 Most Popular Stories for May 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

Injectable Semaglutide Shortage Forces Physicians to Pivot

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

February 2024 Dispatch for the CV Team

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content